HIGHLIGHTS
- What: Taking into account, the aforementioned issues, the aims of the study were to inquire the clinical usefulness of repeating FNAC in ITNs in terms of changing management indications and perform an evaluation of a long-term follow-up of a large cohort of ITNs. The latter categories were the main focus of the study , therefore with the acronymous ITN the authors will refer to TIR3A and Class III (subgroup with "other types of atypia") categories. The authors propose to consider FNAC-rep only for young adult patients, up to a maximum of 55 years and/or . . .

If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.